Theravance Biopharma (TBPH) Gross Margin Growth (3y) (2016 - 2018)

Theravance Biopharma (TBPH) Gross Margin Growth (3y) (2016 - 2018) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -230.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -168.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 193,280.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 589.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 6.06 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 53.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 569.00
10 Theravance Biopharma 880.59 Mn 492.93 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 7,821.00
Sep 30, 2018 -6.00
Jun 30, 2018 91.00
Mar 31, 2018 -811.00
Dec 31, 2017 17,390.00
Sep 30, 2017 -1,722.00
Jun 30, 2017 -2,949.00
Mar 31, 2017 159.00
Dec 31, 2016 -2,013.00
Sep 30, 2016 -174.00
Jun 30, 2016 -425.00
Mar 31, 2016 -423.00